Skip to main navigation
Skip to search
Skip to main content
Augusta University Research Profiles Home
Help & FAQ
Home
Profiles
Research units
Equipment
Grants
Scholarly Output
Datasets
Activities
Prizes
Search by expertise, name or affiliation
Development of endothelin receptor antagonists as potential therapeutic agents
Adviye Ergul
Physiology
Research output
:
Contribution to journal
›
Review article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Development of endothelin receptor antagonists as potential therapeutic agents'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Atherosclerosis
23%
Bosentan
83%
Clinical Trials
19%
Endothelin Receptor Antagonists
78%
Endothelin Receptors
40%
Endothelin-1
63%
Essential Hypertension
30%
Familial Primary Pulmonary Hypertension
38%
Heart Failure
42%
Hypertension
19%
Mitogens
29%
Patents
35%
Pulmonary Hypertension
58%
Therapeutics
9%
Treatment Failure
28%
Vasoconstrictor Agents
32%
Chemical Compounds
Agent Interacting With Transmitter, Hormone or Drug Receptor
32%
Antagonist
54%
Application
9%
Bosentan
52%
Endothelin Receptor Antagonist
100%
Endothelin-1
87%
Mitogen
41%